Niemann, C. U., Dubois, J., Nasserinejad, K., Cunha-Bang, C. d., Kersting, S., Enggaard, L., . . . Levin, M. (2025). Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: Phase 2 VISION/HO141 trial. Elsevier.
Chicago Style (17th ed.) CitationNiemann, Carsten U., et al. Long-term Follow-up of MRD-guided Ibrutinib Plus Venetoclax in Relapsed CLL: Phase 2 VISION/HO141 Trial. Elsevier, 2025.
MLA (9th ed.) CitationNiemann, Carsten U., et al. Long-term Follow-up of MRD-guided Ibrutinib Plus Venetoclax in Relapsed CLL: Phase 2 VISION/HO141 Trial. Elsevier, 2025.
Warning: These citations may not always be 100% accurate.